|
VPS29 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.254000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.506390E-01 |
| Normal-vs-Stage2 |
5.655600E-01 |
| Normal-vs-Stage3 |
7.192400E-01 |
| Normal-vs-Stage4 |
4.691200E-01 |
| Stage1-vs-Stage2 |
8.348200E-01 |
| Stage1-vs-Stage3 |
5.750600E-01 |
| Stage1-vs-Stage4 |
2.536400E-01 |
| Stage2-vs-Stage3 |
8.201000E-01 |
| Stage2-vs-Stage4 |
3.996400E-01 |
| Stage3-vs-Stage4 |
4.804000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.013800E-01 |
| Normal-vs-AfricanAmerican |
1.034320E-02 |
| Normal-vs-Asian |
2.219800E-01 |
| Caucasian-vs-AfricanAmerican |
9.660500E-03 |
| Caucasian-vs-Asian |
4.938000E-01 |
| AfricanAmerican-vs-Asian |
8.195000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.264400E-01 |
| Normal-vs-Female |
1.593350E-01 |
| Male-vs-Female |
5.112800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.857600E-01 |
| Normal-vs-Extreme_Weight |
6.444000E-01 |
| Normal-vs-Obese |
6.246200E-01 |
| Normal-vs-Extreme_Obese |
7.224400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.486600E-01 |
| Normal_Weight-vs-Obese |
8.395600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.709400E-01 |
| Extreme_Weight-vs-Obese |
9.249200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.565400E-01 |
| Obese-vs-Extreme_Obese |
5.750000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.078600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.649780E-01 |
| Normal-vs-Age(61-80Yrs) |
6.039600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.835200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.360810E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.816000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.690000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.395200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.819600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.973200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.294300E-02 |
| Normal-VS-Type2 PRCC |
8.997800E-01 |
| Normal-VS-KIRP CIMP |
3.608400E-01 |
| Normal-VS-Unclassified PRCC |
1.666000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.004050E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.809380E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.293400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.154800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.698850E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.087980E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.576600E-01 |
| Normal-vs-N1 |
7.642200E-01 |
| Normal-vs-N2 |
2.564200E-02 |
| N0-vs-N1 |
9.789800E-01 |
| N0-vs-N2 |
1.526390E-01 |
| N1-vs-N2 |
1.024220E-01 |
|
|
